- Home
- TGL vs PTIX Comparison
TGL vs PTIX Comparison
Compare TGL & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- PTIX
- Stock Information
- Founded
- TGL 2020
- PTIX 1994
- Country
- TGL United States
- PTIX United States
- Employees
- TGL N/A
- PTIX N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- TGL Technology
- PTIX Health Care
- Exchange
- TGL Nasdaq
- PTIX Nasdaq
- Market Cap
- TGL 3.9M
- PTIX 3.3M
- IPO Year
- TGL 2022
- PTIX 2016
- Fundamental
- Price
- TGL $1.05
- PTIX $3.83
- Analyst Decision
- TGL
- PTIX
- Analyst Count
- TGL 0
- PTIX 0
- Target Price
- TGL N/A
- PTIX N/A
- AVG Volume (30 Days)
- TGL 2.9M
- PTIX 210.6K
- Earning Date
- TGL 08-25-2025
- PTIX 08-13-2025
- Dividend Yield
- TGL N/A
- PTIX N/A
- EPS Growth
- TGL N/A
- PTIX N/A
- EPS
- TGL N/A
- PTIX N/A
- Revenue
- TGL $1,468,790.00
- PTIX N/A
- Revenue This Year
- TGL N/A
- PTIX N/A
- Revenue Next Year
- TGL N/A
- PTIX N/A
- P/E Ratio
- TGL N/A
- PTIX N/A
- Revenue Growth
- TGL N/A
- PTIX N/A
- 52 Week Low
- TGL $1.01
- PTIX $2.35
- 52 Week High
- TGL $147.00
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- TGL 32.05
- PTIX 53.21
- Support Level
- TGL $1.02
- PTIX $3.55
- Resistance Level
- TGL $1.11
- PTIX $3.97
- Average True Range (ATR)
- TGL 0.10
- PTIX 0.23
- MACD
- TGL 0.02
- PTIX 0.04
- Stochastic Oscillator
- TGL 6.44
- PTIX 81.83
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.